mt1988
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 25, 2024 (NCT06728176)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07226895 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2025 | Monument Therapeutics Limited, National Institute of Mental Health (NIMH), National Institutes of Health (NIH) |
| NCT06728176 | Phase 1 | Nov 25, 2024 | Monument Therapeutics Limited |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Monument Therapeutics Limited | For profit | 2 | 2 | 2 | 2024 |
| National Institute of Mental Health (NIMH) | Government | 1 | 0 | 1 | 2025 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1